210 related articles for article (PubMed ID: 35027829)
1. RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC.
Chen Y; Shang H; Wang C; Zeng J; Zhang S; Wu B; Cheng W
Int J Nanomedicine; 2022; 17():105-123. PubMed ID: 35027829
[TBL] [Abstract][Full Text] [Related]
2. Sonosensitizer Nanoplatforms Augmented Sonodynamic Therapy-Sensitizing Shikonin-Induced Necroptosis Against Hepatocellular Carcinoma.
Tian H; Shang H; Chen Y; Wu B; Wang C; Wang X; Cheng W
Int J Nanomedicine; 2023; 18():7079-7092. PubMed ID: 38050474
[TBL] [Abstract][Full Text] [Related]
3. Sono-Immunotherapy Mediated Controllable Composite Nano Fluorescent Probes Reprogram the Immune Microenvironment of Hepatocellular Carcinoma.
Chen Y; Wu B; Shang H; Sun Y; Tian H; Yang H; Wang C; Wang X; Cheng W
Int J Nanomedicine; 2023; 18():6059-6073. PubMed ID: 37908671
[TBL] [Abstract][Full Text] [Related]
4. Oxygen-sufficient lipid nanobubbles combined with UTMD for enhanced sonodynamic therapy of Hep-G2 cells.
Tan H; Tian Y; Yang H; Liu Z; Liang X; Li B; Cheng W
J Biomed Mater Res B Appl Biomater; 2021 Nov; 109(11):1796-1806. PubMed ID: 33838006
[TBL] [Abstract][Full Text] [Related]
5. RNA-Seq Technology Reveals the Mechanism of SDT Combined With Novel Nanobubbles Against HCC.
Shang H; Chen Y; Wang C; Zhang S; Wu B; Liang X; Liu Z; Wang Q; Cheng W
Front Mol Biosci; 2021; 8():791331. PubMed ID: 35198599
[TBL] [Abstract][Full Text] [Related]
6. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
7. IR-820@NBs Combined with MG-132 Enhances the Anti-Hepatocellular Carcinoma Effect of Sonodynamic Therapy.
Wang X; Wang C; Tian H; Chen Y; Wu B; Cheng W
Int J Nanomedicine; 2023; 18():6199-6212. PubMed ID: 37933299
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Anticancer Strategy of Sonodynamic Therapy Combined with PI-103 Against Hepatocellular Carcinoma.
Yang H; Jing H; Han X; Tan H; Cheng W
Drug Des Devel Ther; 2021; 15():531-542. PubMed ID: 33603343
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA sequencing reveals the mechanism of sonodynamic therapy combined with a RAS inhibitor in the setting of hepatocellular carcinoma.
Wu B; Yuan Y; Liu J; Shang H; Dong J; Liang X; Wang D; Chen Y; Wang C; Zhou Y; Jing H; Cheng W
J Nanobiotechnology; 2021 Jun; 19(1):177. PubMed ID: 34118951
[TBL] [Abstract][Full Text] [Related]
10. Atovaquone enhances antitumor efficacy of TCR-T therapy by augmentation of ROS-induced ferroptosis in hepatocellular carcinoma.
Chen A; Yu Z; Ma N; Lu X; Zhang Y; Xu W; Wang Y; Xie J; Qin Y; Mo G; Wu S; Hou J; Zhu W
Cancer Immunol Immunother; 2024 Feb; 73(3):49. PubMed ID: 38349553
[TBL] [Abstract][Full Text] [Related]
11. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.
Tan Y; Yang S; Ma Y; Li J; Xie Q; Liu C; Zhao Y
Int J Nanomedicine; 2021; 16():3241-3254. PubMed ID: 34007176
[TBL] [Abstract][Full Text] [Related]
12. Integrated platform of oxygen self-enriched nanovesicles: SP94 peptide-directed chemo/sonodynamic therapy for liver cancer.
Zhang W; Han B; Gao C; Liu X; Peng Y; Gong C; Hu D; Wang N; Tang S; Zhang B; Zhao M; Peng H
Eur J Pharm Biopharm; 2022 Oct; 179():206-220. PubMed ID: 36150614
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembled Aza-Boron-Dipyrromethene for Ferroptosis-Boosted Sonodynamic Therapy.
You C; Li X; Wang D; Chen H; Liang L; Chen Y; Zhao Y; Xiang H
Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202210174. PubMed ID: 35981223
[TBL] [Abstract][Full Text] [Related]
14. Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma.
Chen Y; Luo X; Liu Y; Zou Y; Yang S; Liu C; Zhao Y
Int J Nanomedicine; 2022; 17():3989-4008. PubMed ID: 36105615
[TBL] [Abstract][Full Text] [Related]
15. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.
Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G
Front Immunol; 2022; 13():929089. PubMed ID: 35874689
[TBL] [Abstract][Full Text] [Related]
16. Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy.
Long S; Chen Y; Wang Y; Yao Y; Xiao S; Fu K
Cancer Med; 2023 Jan; 12(2):2134-2147. PubMed ID: 35841206
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Ferroptosis by Oxygen-Boosted Phototherapy Based on a 2-in-1 Nanoplatform of Ferrous Hemoglobin for Tumor Synergistic Therapy.
Xu T; Ma Y; Yuan Q; Hu H; Hu X; Qian Z; Rolle JK; Gu Y; Li S
ACS Nano; 2020 Mar; 14(3):3414-3425. PubMed ID: 32155051
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
19. Nanobubble-mediated co-delivery of Ce6 and miR-195 for synergized sonodynamic and checkpoint blockade combination therapy with elicitation of robust immune response in hepatocellular carcinoma.
Ma Y; Li J; Zhao Y; Hu B; Liu Y; Liu C
Eur J Pharm Biopharm; 2022 Dec; 181():36-48. PubMed ID: 36307001
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional Fe
Liang Z; Wang Y; Wang J; Xu T; Ma S; Liu Q; Zhao L; Wei Y; Lian X; Huang D
Colloids Surf B Biointerfaces; 2023 Jul; 227():113358. PubMed ID: 37207386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
